Michelle Schoettler, MD
-
Research Program
-
Phone Number
-
Email Address
Biography
Michelle L. Schoettler, MD, is a pediatric hematologist at Children's Healthcare of Atlanta and Assistant Professor of Pediatrics in the Emory University School of Medicine. As part of the multidisciplinary team at the Aflac Cancer and Blood Disorders Center, Dr. Schoettler's clinical interest is hematopoietic cellular therapy for hematologic malignancies.
Dr. Schoettler is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.
Education
Dr. Schoettler completed medical school at Wake Forest University School of Medicine, residency training at Boston Children's Hospital, and hematology/oncology/hematopoietic cellular therapy fellowship at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Titles & Roles
-
Assistant Professor, Department of PediatricsEmory University School of Medicine
Professional Memberships
Dr. Schoettler holds professional memberships with the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Pediatric Hematology and Oncology.
Research
Dr. Schoettler's research focus has been the study of transplant associated thrombotic microangiopathy, a potentially life-threatening complication of hematopoietic cellular therapy. She ultimately aims to improve outcomes for pediatric patients after hematopoietic cellular therapy.
|
|
Grants
-
Grant Number Title 1K12CA237806-01 Emory Clinical Oncology Career Development Award K12 Program 5K12CA237806-02 Emory Clinical Oncology Career Development Award K12 Program 5K12CA237806-03 Emory Clinical Oncology Career Development Award K12 Program Publications
Dr. Schoettler has multiple first author publications and presentations at national meetings describing her work.
Title/Journal Authors Publication Date Blood advances
ML Schoettler, L Lehmann, PC Kao, N Chen, S Jodele, S Chonat, KM Williams, WB London, C Duncan, C Dandoy 12/03/2024 American journal of hematology
ML Schoettler, K French, A Harris, E Bryson, L Deeb, Z Hudson, J Obordo, S Chandrakasan, S Parikh, B Watkins, E Stenger, M Qayed, S Chonat, A Westbrook, J Switchenko, KM Williams 01/03/2024 Transplantation and cellular therapy
ML Schoettler, S Patel, E Bryson, L Deeb, B Watkins, M Qayed, S Chandrakasan, T Fitch, K Silvis, J Jones, S Chonat, KM Williams 01/03/2024 Transplantation and cellular therapy
PA Patel, MF Teherani, Y Xiang, V Bernardo, S Chandrakasan, KP Goggin, A Haight, E Horwitz, WH Liang, SH Parikh, ML Schoettler, K Spencer, E Stenger, B Watkins, KM Williams, K Leung, P Jaggi, M Qayed 01/12/2023 Bone marrow transplantation
S Raghunandan, L Gorfinkel, B Bratrude, Y Suessmuth, K Hebert, D Neuberg, KM Williams, ML Schoettler, AA Langston, LS Kean, M Qayed, J Horan, BK Watkins 01/11/2023 Pediatric blood & cancer
C Hughes, A Harris, B Watkins, M Qayed, S Parikh, E Horwitz, E Stenger, KM Williams, ML Schoettler 01/10/2023 Blood advances
S Raghunandan, L Gorfinkel, M Graiser, B Bratrude, Y Suessmuth, S Gillespie, AL Westbrook, KM Williams, ML Schoettler, LS Kean, J Horan, AA Langston, M Qayed, B Watkins 22/08/2023 Blood advances
M Schoettler, E Stenger, K Spencer, D Lutterman, S Rumbika, J Jones, A Haight, S Parikh, M Qayed, B Watkins, L Krishnamurti, KM Williams, S Chonat 09/05/2023 BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
Journal for immunotherapy of cancer
S Raghunandan, M Pauly, WG Blum, M Qayed, MV Dhodapkar, M Elkhalifa, B Watkins, M Schoettler, E Horwitz, S Parikh, S Chandrakasan, K Leung, E Bryson, L Deeb, JL Kaufman, D Worthington-White, A Alazraki, JM Schecter, D Madduri, CC Jackson, E Zudaire, A Taraseviciute-Morris, A Babich, T Nesheiwat, M Vogel, N Lendvai, L Pacaud, KM Williams 01/05/2023 Frontiers in oncology
ML Schoettler, CE Dandoy, A Harris, M Chan, KM Tarquinio, S Jodele, M Qayed, B Watkins, P Kamat, T Petrillo, J Obordo, CS Higham, CC Dvorak, A Westbrook, MS Zinter, KM Williams 01/01/2023 Transplantation and cellular therapy
ML Schoettler, BD Saldana, L Berkenkamp, S Chonat, B Watkins, SJ Rotz, D Simons, E Graf, C Rossi, J Cheng, YA Hammers, H Rytting, KM Williams 01/01/2023 Transplantation and cellular therapy
GDE Cuvelier, M Schoettler, NP Buxbaum, I Pinal-Fernandez, M Schmalzing, JHW Distler, O Penack, BD Santomasso, R Zeiser, K Angstwurm, KPA MacDonald, WT Kimberly, N Taylor, E Bilic, B Banas, M Buettner-Herold, N Sinha, HT Greinix, J Pidala, KR Schultz, KM Williams, Y Inamoto, C Cutler, LM Griffith, SJ Lee, S Sarantopoulos, SZ Pavletic, D Wolff 01/08/2022 Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
Blood advances
S Janardan, E Horwitz, B Watkins, K Williams, S Chandrakasan, M Qayed, S Parikh, S Arnold, F Keller, A Alazraki, M Schoettler, K Leung 24/05/2022 Frontiers in immunology
ML Schoettler, H Bhatt, S Vasu 01/01/2022 Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy.
Current opinion in hematology
M Schoettler, S Chonat, K Williams, L Lehmann 01/11/2021 Blood advances
CE Dandoy, S Rotz, PB Alonso, A Klunk, C Desmond, J Huber, H Ingraham, C Higham, CC Dvorak, C Duncan, M Schoettler, L Lehmann, M Cancio, J Killinger, B Davila, R Phelan, KM Mahadeo, S Khazal, N Lalefar, M Vissa, K Myers, G Wallace, A Nelson, P Khandelwal, D Bhatla, N Gloude, E Anderson, J Huo, P Roehrs, JJ Auletta, R Chima, A Lane, SM Davies, S Jodele 12/01/2021